Alphabet CEO Sundar Pichai announced a significant development from the company's AI research division, DeepMind, in collaboration with Yale University scientists. The project utilized a specialized AI model, Gemma, to create a new system called Cell2Sentence-Scale 27B. This system reportedly generated a novel scientific hypothesis regarding the behavior of certain cancer cells, which was subsequently validated through experiments in living cells by Yale researchers. The announcement highlights the potential for AI to move beyond data analysis and actively contribute to new scientific discoveries by generating and helping to validate new hypotheses in complex fields like cancer research. While presented as a promising proof-of-concept, the discovery is in its early stages and will require further testing and peer-reviewed publication.